ENDRA Life Sciences Inc
NDRA
|
|
| |
|
| Trading Volume | 441,089 |
|
|
2.50 - 0.03 |
| Market Cap Full | $ 253.6K |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | - | -72.6% | -44.2% |
| Q2 | - | - | -9.2% | -37.4% |
| Q3 | - | - | - | -21.1% |
| Q4 | - | - | - | 91% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -50.5 | 6.7 | -51.8 | -53.7 | 6.8 | -60.7 | -25.7 | -59 | - | - | - | - |
| 2023 | |||||||||||
| -1.5 | -4.5 | -40.7 | -29.5 | -7.5 | -4.1 | -12.7 | -5.7 | -4.3 | -15 | 2.7 | 116.8 |
| 2022 | |||||||||||
| -13.3 | -28.7 | -9.6 | -30.5 | -14.5 | 1.3 | 18 | 6.2 | 4.8 | -24.8 | -22.6 | 2186.5 |
| 2021 | |||||||||||
| 153.3 | 26.8 | 7.9 | -7.7 | -13.8 | 5.3 | -16.1 | 3.8 | -9 | -8.7 | -39.8 | -27.3 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.9 | -1.4 | -0.1 |
| Q2 | -0.4 | -1.2 | -0.1 |
| Q3 | -0.4 | -1 | -0.1 |
| Q4 | 0 | -1 | -1.6 |
| A | -1.76 | -4.56 | -1.8 |